Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (4) , 971-976
- https://doi.org/10.1016/j.bmcl.2004.12.052
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug designBioorganic & Medicinal Chemistry Letters, 2004
- Modulation of carbonic anhydrase activity and its applications in therapyExpert Opinion on Therapeutic Patents, 2004
- Designing of Novel Carbonic Anhydrase Inhibitors and ActivatorsCurrent Medicinal Chemistry-Cardiovascular & Hematological Agents, 2004
- Characterization of CA XIII, a Novel Member of the Carbonic Anhydrase Isozyme FamilyJournal of Biological Chemistry, 2004
- Review ArticleJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesityExpert Opinion on Therapeutic Patents, 2003
- Carbonic anhydrase inhibitorsMedicinal Research Reviews, 2002
- Applications of carbonic anhydrase inhibitors and activators in therapyExpert Opinion on Therapeutic Patents, 2002
- Carbonic Anhydrase InhibitorsCurrent Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, 2001
- Carbonic anhydrase inhibitors and their therapeutic potentialExpert Opinion on Therapeutic Patents, 2000